Roy Bannister

7PUBLICATIONS
68CO-AUTHORS
Evolutionary ecologyMolecular targetsOptical technologyGene and molecular therapyAnimal protection (incl. pests and pathogens)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 14, 2025
The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infection.

Courtney Woolsey, Robert W Cross, Victor C Chu

|May 22, 2024
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses.

David R Martinez, Fernando R Moreira, Nicholas J Catanzaro

|Mar 14, 2024
Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus.

Robert W Cross, Courtney Woolsey, Victor C Chu

|Mar 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice.

Alexandra Schäfer, David R Martinez, John J Won

|Dec 30, 2021
Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infection.

Meghan S Vermillion, Eisuke Murakami, Bin Ma

|May 31, 2019
Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge.

Michael K Lo, Friederike Feldmann, Joy M Gary

Pageof 2

Frequent Collaborators

6 joint publications

Darius Babusis

4 joint publications

John P Bilello

3 joint publications

Timothy P Sheahan

3 joint publications

Kimberly T Barrett